1[1]Sherry S. Personal reflections on the evelopment of thrombolytic therapy and its application to acute coronary thrombosis. Am Heart J, 1981;102:1134 ～ 1138
2[2]Fletcher AP, Alkjacrsing N, Smyrniotis FE, Sherry S. The treatment of patients suffering from early myocardial infarction with massive and prolonged streptoknase therapy. Trans Assoc Am Plysicians, 1958; 71: 287
3[3]Schroder R, Biamino G, yon Leitner ER, et al. Intravenous short - term infusion of streptokinase in acute myocardial infaction. Circulation, 1983;67:536 ～ 548
4[4]Rogers WJ, Mantle JA, Hood WP Jr, et al. Prospective randomized trial of intravenous and intracoronary streptokinase in acute myocardial infarction. Circulation, 1983:1051 ～ 1061
5[5]Anderson JL, Marshall HW, Askins JC, et al. A randomized trial of intravenous and intracoronary streptokinase in patients with acute myocardial iniarction. Circulation, 1984; 70: 606 ～ 608
6[6]Fibrinolytic Therapy Trialists. (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute cyocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more tha 100 patients. Lancet, 1994;343:311 ～ 322
7[7]Hillis LD.Forman S,Braunwald E.Risk stratilication before thrombolytic therapy in patients with acute myocardial infarction: the Thrombolysis in Myocardial Infaction(TIMI)Phase Ⅱ co- Investigators. J Am Coll Cardiol, 1990; 16:313 ～ 315
